Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001

This study has been completed.
Information provided by (Responsible Party):
Kyowa Kirin Pharmaceutical Development, Inc. ( Kyowa Hakko Kirin Pharma, Inc. ) Identifier:
First received: October 19, 2010
Last updated: June 14, 2016
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: August 26, 2013